Genomed Spólka Akcyjna Dividends and Buybacks
Dividend criteria checks 0/6
Genomed Spólka Akcyjna does not currently pay a dividend.
Key information
0%
Dividend yield
2.2%
Buyback Yield
| Total Shareholder Yield | 2.2% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | zł1.000 |
| Payout ratio | 0% |
Recent dividend and buyback updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if GEN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if GEN's dividend payments have been increasing.
Dividend Yield vs Market
| Genomed Spólka Akcyjna Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (GEN) | 0% |
| Market Bottom 25% (PL) | 2.9% |
| Market Top 25% (PL) | 8.1% |
| Industry Average (Biotechs) | 1.6% |
| Analyst forecast (GEN) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate GEN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate GEN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: GEN is not paying a notable dividend for the Polish market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as GEN has not reported any payouts.